Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
Neuromuscular transmission failure in myasthenia gravis (MG) is most commonly elicited by autoantibodies (ab) to the acetylcholine receptor or the muscle-specific kinase, constituting AChR-MG and MuSK-MG. It is controversial whether these MG subtypes arise through different T helper (Th) 1, Th2 or T...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0123546 |
| _version_ | 1798032675669278720 |
|---|---|
| author | Vuslat Yilmaz Piraye Oflazer Fikret Aysal Hacer Durmus Kostas Poulas Sibel P Yentur Yesim Gulsen-Parman Socrates Tzartos Alexander Marx Erdem Tuzun Feza Deymeer Güher Saruhan-Direskeneli |
| author_facet | Vuslat Yilmaz Piraye Oflazer Fikret Aysal Hacer Durmus Kostas Poulas Sibel P Yentur Yesim Gulsen-Parman Socrates Tzartos Alexander Marx Erdem Tuzun Feza Deymeer Güher Saruhan-Direskeneli |
| author_sort | Vuslat Yilmaz |
| collection | DOAJ |
| description | Neuromuscular transmission failure in myasthenia gravis (MG) is most commonly elicited by autoantibodies (ab) to the acetylcholine receptor or the muscle-specific kinase, constituting AChR-MG and MuSK-MG. It is controversial whether these MG subtypes arise through different T helper (Th) 1, Th2 or Th17 polarized immune reactions and how these reactions are blunted by immunosuppression. To address these questions, plasma levels of cytokines related to various Th subtypes were determined in patients with AChR-MG, MuSK-MG and healthy controls (CON). Peripheral blood mononuclear cells (PBMC) were activated in vitro by anti-CD3, and cytokines were quantified in supernatants. In purified blood CD4+ T cells, RNA of various cytokines, Th subtype specific transcription factors and the co-stimulatory molecule, CD40L, were quantified by qRT-PCR. Plasma levels of Th1, Th2 and Th17 related cytokines were overall not significantly different between MG subtypes and CON. By contrast, in vitro stimulated PBMC from MuSK-MG but not AChR-MG patients showed significantly increased secretion of the Th1, Th17 and T follicular helper cell related cytokines, IFN-γ, IL-17A and IL-21. Stimulated expression of IL-4, IL-6, IL-10 and IL-13 was not significantly different. At the RNA level, expression of CD40L by CD4+ T cells was reduced in both AChR-MG and MuSK-MG patients while expression of Th subset related cytokines and transcription factors were normal. Immunosuppression treatment had two effects: First, it reduced levels of IL12p40 in the plasma of AChR-MG and MuSK-MG patients, leaving other cytokine levels unchanged; second, it reduced spontaneous secretion of IFN-γ and increased secretion of IL-6 and IL-10 by cultured PBMC from AChR-MG, but not MuSK-MG patients. We conclude that Th1 and Th17 immune reactions play a role in MuSK-MG. Immunosuppression attenuates the Th1 response in AChR-MG and MuSK-MG, but otherwise modulates immune responses in AChR-MG and MuSK-MG patients differentially. |
| first_indexed | 2024-04-11T20:16:35Z |
| format | Article |
| id | doaj.art-0de3ce75fb9243d1834b5949a1492d14 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-11T20:16:35Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-0de3ce75fb9243d1834b5949a1492d142022-12-22T04:04:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012354610.1371/journal.pone.0123546Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.Vuslat YilmazPiraye OflazerFikret AysalHacer DurmusKostas PoulasSibel P YenturYesim Gulsen-ParmanSocrates TzartosAlexander MarxErdem TuzunFeza DeymeerGüher Saruhan-DireskeneliNeuromuscular transmission failure in myasthenia gravis (MG) is most commonly elicited by autoantibodies (ab) to the acetylcholine receptor or the muscle-specific kinase, constituting AChR-MG and MuSK-MG. It is controversial whether these MG subtypes arise through different T helper (Th) 1, Th2 or Th17 polarized immune reactions and how these reactions are blunted by immunosuppression. To address these questions, plasma levels of cytokines related to various Th subtypes were determined in patients with AChR-MG, MuSK-MG and healthy controls (CON). Peripheral blood mononuclear cells (PBMC) were activated in vitro by anti-CD3, and cytokines were quantified in supernatants. In purified blood CD4+ T cells, RNA of various cytokines, Th subtype specific transcription factors and the co-stimulatory molecule, CD40L, were quantified by qRT-PCR. Plasma levels of Th1, Th2 and Th17 related cytokines were overall not significantly different between MG subtypes and CON. By contrast, in vitro stimulated PBMC from MuSK-MG but not AChR-MG patients showed significantly increased secretion of the Th1, Th17 and T follicular helper cell related cytokines, IFN-γ, IL-17A and IL-21. Stimulated expression of IL-4, IL-6, IL-10 and IL-13 was not significantly different. At the RNA level, expression of CD40L by CD4+ T cells was reduced in both AChR-MG and MuSK-MG patients while expression of Th subset related cytokines and transcription factors were normal. Immunosuppression treatment had two effects: First, it reduced levels of IL12p40 in the plasma of AChR-MG and MuSK-MG patients, leaving other cytokine levels unchanged; second, it reduced spontaneous secretion of IFN-γ and increased secretion of IL-6 and IL-10 by cultured PBMC from AChR-MG, but not MuSK-MG patients. We conclude that Th1 and Th17 immune reactions play a role in MuSK-MG. Immunosuppression attenuates the Th1 response in AChR-MG and MuSK-MG, but otherwise modulates immune responses in AChR-MG and MuSK-MG patients differentially.https://doi.org/10.1371/journal.pone.0123546 |
| spellingShingle | Vuslat Yilmaz Piraye Oflazer Fikret Aysal Hacer Durmus Kostas Poulas Sibel P Yentur Yesim Gulsen-Parman Socrates Tzartos Alexander Marx Erdem Tuzun Feza Deymeer Güher Saruhan-Direskeneli Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. PLoS ONE |
| title | Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. |
| title_full | Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. |
| title_fullStr | Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. |
| title_full_unstemmed | Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. |
| title_short | Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. |
| title_sort | differential cytokine changes in patients with myasthenia gravis with antibodies against achr and musk |
| url | https://doi.org/10.1371/journal.pone.0123546 |
| work_keys_str_mv | AT vuslatyilmaz differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT pirayeoflazer differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT fikretaysal differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT hacerdurmus differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT kostaspoulas differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT sibelpyentur differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT yesimgulsenparman differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT socratestzartos differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT alexandermarx differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT erdemtuzun differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT fezadeymeer differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk AT guhersaruhandireskeneli differentialcytokinechangesinpatientswithmyastheniagraviswithantibodiesagainstachrandmusk |